Schizophrenia long-acting antipsychotics initiation index (SLAAII)

INTRODUCTION: Background In individuals with schizophrenia, long-acting injectable antipsychotics (LAIs) have been shown to be beneficial in preventing relapse. An important issue in these individuals is poor medication adherence, which can negatively affect outcomes. Although currently underutilize...

Descripción completa

Detalles Bibliográficos
Autores principales: Ifteni, P., Teodorescu, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2021
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9479958/
http://dx.doi.org/10.1192/j.eurpsy.2021.2149

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9479958/
http://dx.doi.org/10.1192/j.eurpsy.2021.2149

Ejemplares similares